Infection and blood transfusion: a guide to donor screening

In recent years, blood-component therapy has become more accessible in veterinary practice. As with human medicine, care must be taken to minimize the risk of disease transmission from donor to recipient. Determining the appropriate diseases to screen for is complicated by regional variations in disease incidence, the existence of chronic carrier states for some diseases, the difficulty in screening-test selection, and testing cost. The feline diseases considered include retroviral infections, feline coronaviruses, ehrlichiosis ( Ehrlichia canis-like), anaplasmosis ( Anaplasma phagocytophilum), neorickettsiosis ( Neorickettsia risticii), hemoplasmosis ( Mycoplasma hemofelis and M. hemominutum, previously feline hemobartonellosis), and cytauxzoonosis ( Cytauxzoon felis). The canine diseases considered in this paper include babesiosis ( Babesia canis and B. gibsonii,) ehrlichiosis ( E. canis and E. ewingii), anaplasmosis ( A. phagocytophilum), neorickettsiosis ( N. risticii var. atypicalis), leishmaniasis ( Leishmania donovani complex), brucellosis ( Brucella canis), hemoplasmosis ( M. hemocanis, previously canine hemobartonellosis), and bartonellosis ( Bartonella vinsonii).